Spur Therapeutics today announced that it has selected a lead development candidate in its gene therapy program for a genetically defined subset of Parkinson’s disease characterized by mutations in ...
Beta-blocker drugs -- commonly used to treat heart and blood pressure issues -- may slow the progression of Huntington's disease (HD), according to a new study.
In a groundbreaking study that could change the way we understand and approach Parkinson’s disease, researchers are delving into the mysterious link between violent dreams and the onset of this ...
Our community Parkinson’s service works with anyone who has a confirmed diagnosis of Parkinson’s disease. We offer coordinated care across the pathway, providing and facilitating care and support for ...
The Association of Movement Disorder Advanced Practice Providers (AMDAPP) is proud to announce the launch of the Certification of Movement & Related Disorder Specialist (CMRD). This pioneering ...
Ohio State University-Lima Dean Margaret Young wants to dispel the misconception that regional college campuses are inferior to the main campus in Columbus. Roughly 740 students are enrolled at the ...